Search PubMedSearch

Biomedical subjects

M Marzaloni

Publications and source records attributed to M Marzaloni.

6 recordsLinked to original sources

Usefulness of 1-hour and 24-hour heart rate Holter inbuilt in new TX* rate adaptive pacemakers.

The rate adaptive TX* pacemaker uses the evoked QT interval as an indicator of physiological demand. In order to obtain a rate adaptation close to physiological patterns we used in the past, in each patient, on the slope value and/or the T wave sensing window, controlling via exercise stress testing and Holter the results achieved. It was an expensive method, but the system produced effective rate responsive pacing. The new series of TX* pacemakers (Quintech 919 and Rhythmyx), beside the dynamic slope feature, are equipped with a 1-hour heart rate Holter (HRH) that can be used during effort without the need for manually recording the heart rate. In this mode TX* pacemakers calculate the average heart rate over 20-second periods and stores the values continuously for 1 hour. In addition, a 24-hour HRH is available, which calculates the average heart rate over 7.5-minute periods, showing heart rate trend during the last day prior to interrogation. Each HRH can be accessed by the programmer and printed out. Using four Quintech 919* and five Rhythmyx units, the inbuilt HRH proved its utility by making the heart rate adaptation checking procedure easier, faster, and more economic.

Atrial Fibrillation

A simple new method for atrial triggered pacemaker. Preliminary clinical trials.

Inadequacy of cardiac output in the ventricular paced complete heart block is generally related to lack of rate adaptation to varying atrial contribution. The status of the art in leads technology had not yet freed the clinicians from the necessity to use a double lead system (atrial and ventricular) in order to maintain the atrial synchronization. Authors present a new simple catheter with double electrode (atrial receptor and ventricular stimulator) which, connecting to a new conceived VAT generator, let to obtain atrial synchronization with a single catheter-electrode implantation. External units were tried in 22 patients who needed temporary treatment. The results appear to be positive in all cases and encourage the Authors to continue with the task undertaken until the system is made implantable.

Clinical Trials as Topic

[Lidocaine administration in a patient with Wolff-Parkinson-White syndrome and atrial fibrillation (author's transl)].

This report describes a case of Wolff-Parkinson-White syndrome with atrial fibrillation in which the ventricular complexes conducted over the accessory pathway have promptly disappeared with the use of intravenously administered lidocaine. Lidocaine is suggested as the most suitable drug in such situations. Finally possible connections are presented between high dosage administered lidocaine and conversion to normal sinus rhythm.

Atrial Fibrillation